StockTipsArenaBeta

BUY Apollo Hospitals Enterprise Ltd. — Prabhudas Lilladher

BUYApollo Hospitals Enterprise Ltd.

byPrabhudas LilladherHorizon: NA (inferred 1 year)2 Jul 2025via Institutional / Brokerage Research

Entry₹7,441Inferred
Target₹8,350
Total upside +12.22% (call closed)
Stop lossNot given
Exit₹8,35021 May 2026, 12:05 pm
Target hit+12.22%0.00%upside left
Follow Prabhudas Lilladher for new calls(67% target hit, 412 closed calls)Get alertsWatch APOLLOHOSP for new buy/sell callsGet alertsSee 12 active Long-term calls on APOLLOHOSPSee 36 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 5:39 pm IST
4 supporting1 neutral0 opposing
Supports the BUY call (4)

Apollo Hospitals Enterprise Limited announced the combination of Apollo Cradle and Fertility and Cloudnine to form a large integrated maternity and fertility care platform in India.

NSE · Press Release·20 May · today

(opens in new tab)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·19 May · yesterday

Apollo Hospitals Enterprise Ltd. has had its long-term bank facility and instrument rated 'ICRA AAA/Stable' and its short-term rating affirmed at 'ICRA A1+' by ICRA Limited.

NSE · Credit Rating- New·19 May · 2d ago

(opens in new tab)

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·30 Mar · 2mo ago

Neutral / worth noting (1)

Apollo Hospitals Enterprise Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

NSE · Outcome of Board Meeting·20 May · today

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.